BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 33547568)

  • 1. Post-Visit Patient Understanding About Newly Prescribed Medications.
    Ho T; Campos BS; Tarn DM
    J Gen Intern Med; 2021 Nov; 36(11):3307-3310. PubMed ID: 33547568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intervention to enhance communication about newly prescribed medications.
    Tarn DM; Paterniti DA; Orosz DK; Tseng CH; Wenger NS
    Ann Fam Med; 2013; 11(1):28-36. PubMed ID: 23319503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How much time does it take to prescribe a new medication?
    Tarn DM; Paterniti DA; Kravitz RL; Heritage J; Liu H; Kim S; Wenger NS
    Patient Educ Couns; 2008 Aug; 72(2):311-9. PubMed ID: 18406562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National Ambulatory Medical Care Survey: 2001 summary.
    Cherry DK; Burt CW; Woodwell DA
    Adv Data; 2003 Aug; (337):1-44. PubMed ID: 12924075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient, Physician, Medical Assistant, and Office Visit Factors Associated With Medication List Agreement.
    Reedy AB; Yeh JY; Nowacki AS; Hickner J
    J Patient Saf; 2016 Mar; 12(1):18-24. PubMed ID: 24647267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Life disruptions for midlife and older adults with high out-of-pocket health expenditures.
    Grande D; Barg FK; Johnson S; Cannuscio CC
    Ann Fam Med; 2013; 11(1):37-42. PubMed ID: 23319504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physician communication when prescribing new medications.
    Tarn DM; Heritage J; Paterniti DA; Hays RD; Kravitz RL; Wenger NS
    Arch Intern Med; 2006 Sep; 166(17):1855-62. PubMed ID: 17000942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-Oncologist Communication Regarding Oral Chemotherapy During Routine Office Visits.
    Nguyen BKH; Wu BS; Sanoff HK; Lafata JE
    JCO Oncol Pract; 2020 Aug; 16(8):e660-e667. PubMed ID: 32119593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-Physician Communication on Medication Cost during Glaucoma Visits.
    Slota C; Davis SA; Blalock SJ; Carpenter DM; Muir KW; Robin AL; Sleath B
    Optom Vis Sci; 2017 Dec; 94(12):1095-1101. PubMed ID: 29194229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physician and patient factors associated with the prescribing of medications for sleep difficulties that are associated with high abuse potential or are expensive: an analysis of data from the National Ambulatory Medical Care Survey for 1996-2001.
    Rasu RS; Shenolikar RA; Nahata MC; Balkrishnan R
    Clin Ther; 2005 Dec; 27(12):1970-9. PubMed ID: 16507384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physician communication about the cost and acquisition of newly prescribed medications.
    Tarn DM; Paterniti DA; Heritage J; Hays RD; Kravitz RL; Wenger NS
    Am J Manag Care; 2006 Nov; 12(11):657-64. PubMed ID: 17090222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How do physicians conduct medication reviews?
    Tarn DM; Paterniti DA; Kravitz RL; Fein S; Wenger NS
    J Gen Intern Med; 2009 Dec; 24(12):1296-302. PubMed ID: 19813063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between patient age and duration of physician visit in ambulatory setting: does one size fit all?
    Lo A; Ryder K; Shorr RI
    J Am Geriatr Soc; 2005 Jul; 53(7):1162-7. PubMed ID: 16108934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of obesity on time spent with the provider and number of medications managed during office-based physician visits using a cross-sectional, national health survey.
    Pearson WS; Bhat-Schelbert K; Ford ES; Mokdad AH
    BMC Public Health; 2009 Nov; 9():436. PubMed ID: 19948026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physician counseling for hypertension: what do doctors really do?
    Bell RA; Kravitz RL
    Patient Educ Couns; 2008 Jul; 72(1):115-21. PubMed ID: 18328663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication risk communication during rheumatology office visits.
    Blalock SJ; DeVellis BM; DeVellis RF; Chewning B; Jonas BL; Sleath BL
    Arthritis Care Res (Hoboken); 2015 Feb; 67(2):161-8. PubMed ID: 25073718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visits to office-based physicians in the United States for medication-related morbidity.
    Aparasu RR
    J Am Pharm Assoc (Wash); 1999; 39(3):332-7. PubMed ID: 10363459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National trends in psychotropic medication polypharmacy in office-based psychiatry.
    Mojtabai R; Olfson M
    Arch Gen Psychiatry; 2010 Jan; 67(1):26-36. PubMed ID: 20048220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New prescriptions: how well do patients remember important information?
    Tarn DM; Flocke SA
    Fam Med; 2011 Apr; 43(4):254-9. PubMed ID: 21499998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescribing new medications: a taxonomy of physician-patient communication.
    Tarn DM; Heritage J; Paterniti DA; Hays RD; Kravitz RL; Wenger NS
    Commun Med; 2008; 5(2):195-208. PubMed ID: 19644569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.